Dr. Sara Lustigman, New York Blood Center. CDIPD collaborates with the Laboratory of Molecular Parasitology, headed by Sara Lustiman, Ph.D, in filarid parasites, specifically those that cause onchocerciasis, also known as "river blindness", and lymphatic filariasis, also known as elephantiasis. The joint effort is focused, along with Anacor and Rahul Singh, in discovering new therapeutics to treat these diseases.
Dr. Sharon Reed, UCSD, collaborates with CDIPD personnel studying compounds that are active versus Entamoeba histolytica and Giardia lamblia. Her laboratory was instrumental in the discovery of auranofin as a repurposed drug for the treatment of amebiasis. She will be directing a clinical trial in Bangladesh studying the effect of auranofin versus both amoeba and giardia.